IL133253A0 - Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them - Google Patents
Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising themInfo
- Publication number
- IL133253A0 IL133253A0 IL13325399A IL13325399A IL133253A0 IL 133253 A0 IL133253 A0 IL 133253A0 IL 13325399 A IL13325399 A IL 13325399A IL 13325399 A IL13325399 A IL 13325399A IL 133253 A0 IL133253 A0 IL 133253A0
- Authority
- IL
- Israel
- Prior art keywords
- sub
- sup
- coxr
- chlorophyll
- bacteriochlorophyll
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
- A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/10—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to heterocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Priority Applications (21)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL13325399A IL133253A0 (en) | 1999-12-01 | 1999-12-01 | Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| JP2001540987A JP2003515538A (ja) | 1999-12-01 | 2000-12-01 | クロロフィル及びバクテリオクロロフィルのエステル類、その調製及びそれを含む医薬組成物 |
| AU17292/01A AU777761B2 (en) | 1999-12-01 | 2000-12-01 | Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| ES00979916T ES2250214T3 (es) | 1999-12-01 | 2000-12-01 | Esteres de clorofila y bacterioclorofila, su preparacion y composiciones farmaceuticas que los comprenden. |
| DK00979916T DK1246826T3 (da) | 1999-12-01 | 2000-12-01 | Chlorophyl- og bakteriochlorophylestere, deres fremstilling og farmaceutiske præparater omfattende disse estere |
| IL14987500A IL149875A0 (en) | 1999-12-01 | 2000-12-01 | Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| CA002392989A CA2392989A1 (en) | 1999-12-01 | 2000-12-01 | Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| MXPA02005455A MXPA02005455A (es) | 1999-12-01 | 2000-12-01 | Esteres de clorofila y bacterioclorofila, su preparacion y composiciones farmaceuticas que los contienen. |
| PL00356391A PL356391A1 (pl) | 1999-12-01 | 2000-12-01 | Estry chlorofilu i bakteriochlorofilu, sposób ichwytwarzania oraz zawierające je kompozycje farmaceutyczne |
| HK03108847.5A HK1056557B (en) | 1999-12-01 | 2000-12-01 | Transesterification process for preparation of synthetic chlorophyll and bacteriochlorophyll derivative |
| BR0016051-2A BR0016051A (pt) | 1999-12-01 | 2000-12-01 | ésteres clorofìlicos e bacterioclorofìlicos, sua preparação e composições farmacêuticas que os compreendem |
| US10/148,552 US7169753B2 (en) | 1999-12-01 | 2000-12-01 | Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| PCT/IL2000/000811 WO2001040232A1 (en) | 1999-12-01 | 2000-12-01 | Chlorophyll and bacteriochlorophyll esters, and their preparation |
| DE60023748T DE60023748T2 (de) | 1999-12-01 | 2000-12-01 | Chlorophyll- und bacteriochlorophyllester, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen |
| AT00979916T ATE308545T1 (de) | 1999-12-01 | 2000-12-01 | Chlorophyll- und bacteriochlorophyllester, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen |
| EP00979916A EP1246826B1 (de) | 1999-12-01 | 2000-12-01 | Chlorophyll- und bacteriochlorophyllester, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen |
| CNB008186030A CN1222526C (zh) | 1999-12-01 | 2000-12-01 | 制备合成的叶绿素或细菌叶绿素衍生物的酯交换的方法 |
| HU0204167A HU224553B1 (hu) | 1999-12-01 | 2000-12-01 | Átészterezési eljárás klorofill- és bakterioklorofill C-133, C-173 diészterek előállítására |
| RU2002117287/04A RU2250905C2 (ru) | 1999-12-01 | 2000-12-01 | Способ трансэтерификации для получения синтетического производного хлорофилла или бактериохлорофилла |
| NO20022599A NO323208B1 (no) | 1999-12-01 | 2002-05-31 | Omforestringsfremgangsmate for fremstilling av klorofyll- og bakterioklorofyll-C13(3), C-17(3) diestere |
| US10/414,007 US7045117B2 (en) | 1999-12-01 | 2003-04-16 | Method for tumor diagnosis comprising administering of palladium-substituted bacteriochlorophyll derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL13325399A IL133253A0 (en) | 1999-12-01 | 1999-12-01 | Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL133253A0 true IL133253A0 (en) | 2001-04-30 |
Family
ID=11073554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13325399A IL133253A0 (en) | 1999-12-01 | 1999-12-01 | Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7169753B2 (de) |
| EP (1) | EP1246826B1 (de) |
| JP (1) | JP2003515538A (de) |
| CN (1) | CN1222526C (de) |
| AT (1) | ATE308545T1 (de) |
| AU (1) | AU777761B2 (de) |
| BR (1) | BR0016051A (de) |
| CA (1) | CA2392989A1 (de) |
| DE (1) | DE60023748T2 (de) |
| DK (1) | DK1246826T3 (de) |
| ES (1) | ES2250214T3 (de) |
| HU (1) | HU224553B1 (de) |
| IL (1) | IL133253A0 (de) |
| MX (1) | MXPA02005455A (de) |
| NO (1) | NO323208B1 (de) |
| PL (1) | PL356391A1 (de) |
| RU (1) | RU2250905C2 (de) |
| WO (1) | WO2001040232A1 (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6887260B1 (en) | 1998-11-30 | 2005-05-03 | Light Bioscience, Llc | Method and apparatus for acne treatment |
| US20060212025A1 (en) | 1998-11-30 | 2006-09-21 | Light Bioscience, Llc | Method and apparatus for acne treatment |
| US9192780B2 (en) | 1998-11-30 | 2015-11-24 | L'oreal | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders |
| WO2002013820A1 (en) * | 2000-08-11 | 2002-02-21 | Ceramoptec Industries, Inc. | Photosensitizing ointment |
| US7715901B2 (en) | 2002-05-08 | 2010-05-11 | Yeda Research And Development Co. Ltd. | Sensitized online BOLD-MRI imaging method |
| IL152900A0 (en) * | 2002-11-17 | 2003-06-24 | Yeda Res & Dev | Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses |
| CA2533129A1 (en) | 2003-07-31 | 2005-02-10 | Light Bioscience, Llc | System and method for the photodynamic treatment of burns, wounds, and related skin disorders |
| CA2437638A1 (en) | 2003-08-20 | 2005-02-20 | John Robert North | Photodynamic therapy |
| CA2457214A1 (en) | 2004-02-06 | 2005-08-06 | Qlt Inc. | Photodynamic therapy for the treatment of acne |
| CN1980661B (zh) * | 2004-06-07 | 2011-09-28 | 耶达研究及发展有限公司 | 阳离子细菌叶绿素衍生物及其用途 |
| MX2007000338A (es) | 2004-06-09 | 2007-03-28 | Quadra Logic Tech Inc | Terapia fotodinamica para el tratamiento de trastornos hiperactivos de glandulas sebaceas. |
| GB2415372A (en) * | 2004-06-23 | 2005-12-28 | Destiny Pharma Ltd | Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent |
| RU2303966C2 (ru) * | 2005-10-11 | 2007-08-10 | Федеральное Государственное Учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. академика С.Н. Федорова Федерального агентства по здравоохранению и социальному развитию | Способ снижения поверхностной дозы офтальмоаппликатора при проведении брахитерапии внутриглазных новообразований |
| RU2345803C2 (ru) * | 2006-11-30 | 2009-02-10 | Закрытое Акционерное Общество "Исследовательские лаборатории "РАДА-ФАРМА" | Способ фотоиммунотерапии фотосенсибилизатором, активируемым волновой энергией вне организма человека |
| RU2336917C1 (ru) * | 2007-05-29 | 2008-10-27 | Государственное образовательное учреждение дополнительного профессионального образования Российская медицинская академия последипломного образования Федерального агентства по здравоохранению и социальному развитию (ГОУДПО РМАПО Росздрава) | Способ лечения больных псориазом |
| US20090036952A1 (en) | 2007-07-30 | 2009-02-05 | National Yang-Ming University | Induction driven light module and use thereof |
| FR2924021B1 (fr) * | 2007-11-27 | 2010-08-13 | Du Vernet Michele Eymard | Composition pour le traitement de la peau par therapie photodynamique |
| CN101925382A (zh) * | 2008-01-28 | 2010-12-22 | 耶达研究及发展有限公司 | 内窥镜成像光动力学治疗系统及其使用方法 |
| DK2257309T3 (da) | 2008-02-27 | 2020-01-20 | Yeda Res And Development Company Ltd | Rgd-(bakterie)chlorophyl-konjugater til anvendelse ved diagnose af tumorer, der omfatter nekrotiske domæner |
| US20130289089A1 (en) | 2011-01-13 | 2013-10-31 | Jerome A. Morris | Pharmaceutical Compositions for Topical Delivery of Photosensitizers and Uses Thereof |
| DK2747763T3 (da) * | 2011-08-23 | 2021-03-29 | Yeda Res & Dev | (bacterio-)chlorofyllfotosensibilisatorer til behandling af øjensygdomme og -lidelser |
| KR20150030763A (ko) | 2012-07-11 | 2015-03-20 | 더미라, 인코포레이티드 | 감광제의 국부 전달을 위한 약제학적 조성물 및 이의 이용 |
| US10117942B2 (en) | 2013-07-12 | 2018-11-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Photoactivatable lipid-based nanoparticles as vehicles for dual agent delivery |
| EP3442582A1 (de) * | 2016-04-10 | 2019-02-20 | Yeda Research and Development Co. Ltd | Kombinationstherapien zur behandlung von krebs mit einem bakteriochlorophyllderivat |
| CN108341827A (zh) * | 2018-02-02 | 2018-07-31 | 浙江海正药业股份有限公司 | 一种制备脱镁细菌叶绿素a及脱镁细菌叶绿素a酯的方法 |
| CN108191877A (zh) * | 2018-02-05 | 2018-06-22 | 云南瑞宝生物科技股份有限公司 | 一种从蚕沙中提取和纯化叶绿素的方法 |
| WO2020014522A1 (en) | 2018-07-12 | 2020-01-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Binary lipid bilayer-containing vesicles comprising embedded cytotoxic agents and methods of making and using the same |
| CN111171030B (zh) * | 2018-11-12 | 2022-11-22 | 浙江海正药业股份有限公司 | 细菌叶绿素衍生物及其制备方法 |
| CN111848656B (zh) * | 2020-06-24 | 2023-03-14 | 天津大学 | 离子修饰的原卟啉镓化合物及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU857139A1 (ru) * | 1979-11-02 | 1981-08-23 | Предприятие П/Я В-2343 | Способ получени порфиринов,содержащих изоциклическое метилциклопентановое кольцо |
| US5171741A (en) | 1989-04-21 | 1992-12-15 | Health Research, Inc. | Bacteriochlorophyll-a derivatives useful in photodynamic therapy |
| DE4121867A1 (de) | 1991-07-02 | 1993-01-07 | Leifeld & Lemke Maschf | Vorrichtung zur pruefung der dichtigkeit von mit deckeln luftdicht verschlossenen bechern |
| DE4121876A1 (de) * | 1991-07-02 | 1993-01-14 | Scheer Hugo | Modifizierte bakteriochlorophylle, verfahren zu ihrer herstellung und ihre verwendung |
| IL102645A (en) * | 1992-07-26 | 1998-02-22 | Yeda Res & Dev | Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| IL116126A0 (en) * | 1995-11-24 | 1996-01-31 | Yeda Res & Dev | Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them |
-
1999
- 1999-12-01 IL IL13325399A patent/IL133253A0/xx unknown
-
2000
- 2000-12-01 DE DE60023748T patent/DE60023748T2/de not_active Expired - Fee Related
- 2000-12-01 EP EP00979916A patent/EP1246826B1/de not_active Expired - Lifetime
- 2000-12-01 MX MXPA02005455A patent/MXPA02005455A/es active IP Right Grant
- 2000-12-01 HU HU0204167A patent/HU224553B1/hu not_active IP Right Cessation
- 2000-12-01 PL PL00356391A patent/PL356391A1/xx not_active Application Discontinuation
- 2000-12-01 DK DK00979916T patent/DK1246826T3/da active
- 2000-12-01 AT AT00979916T patent/ATE308545T1/de not_active IP Right Cessation
- 2000-12-01 BR BR0016051-2A patent/BR0016051A/pt not_active Application Discontinuation
- 2000-12-01 CN CNB008186030A patent/CN1222526C/zh not_active Expired - Fee Related
- 2000-12-01 WO PCT/IL2000/000811 patent/WO2001040232A1/en not_active Ceased
- 2000-12-01 CA CA002392989A patent/CA2392989A1/en not_active Abandoned
- 2000-12-01 US US10/148,552 patent/US7169753B2/en not_active Expired - Fee Related
- 2000-12-01 AU AU17292/01A patent/AU777761B2/en not_active Ceased
- 2000-12-01 RU RU2002117287/04A patent/RU2250905C2/ru not_active IP Right Cessation
- 2000-12-01 JP JP2001540987A patent/JP2003515538A/ja not_active Abandoned
- 2000-12-01 ES ES00979916T patent/ES2250214T3/es not_active Expired - Lifetime
-
2002
- 2002-05-31 NO NO20022599A patent/NO323208B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL356391A1 (pl) | 2004-06-28 |
| US7169753B2 (en) | 2007-01-30 |
| CN1222526C (zh) | 2005-10-12 |
| RU2250905C2 (ru) | 2005-04-27 |
| HK1056557A1 (en) | 2004-02-20 |
| DE60023748D1 (de) | 2005-12-08 |
| HUP0204167A3 (en) | 2004-08-30 |
| ES2250214T3 (es) | 2006-04-16 |
| DE60023748T2 (de) | 2006-08-03 |
| EP1246826A1 (de) | 2002-10-09 |
| WO2001040232A1 (en) | 2001-06-07 |
| CA2392989A1 (en) | 2001-06-07 |
| JP2003515538A (ja) | 2003-05-07 |
| MXPA02005455A (es) | 2002-11-29 |
| NO20022599D0 (no) | 2002-05-31 |
| WO2001040232A9 (en) | 2002-09-12 |
| DK1246826T3 (da) | 2006-01-02 |
| BR0016051A (pt) | 2002-07-23 |
| ATE308545T1 (de) | 2005-11-15 |
| EP1246826B1 (de) | 2005-11-02 |
| NO20022599L (no) | 2002-07-11 |
| HUP0204167A2 (hu) | 2003-03-28 |
| CN1425015A (zh) | 2003-06-18 |
| US20030148926A1 (en) | 2003-08-07 |
| HU224553B1 (hu) | 2005-10-28 |
| AU1729201A (en) | 2001-06-12 |
| AU777761B2 (en) | 2004-10-28 |
| NO323208B1 (no) | 2007-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL356391A1 (pl) | Estry chlorofilu i bakteriochlorofilu, sposób ichwytwarzania oraz zawierające je kompozycje farmaceutyczne | |
| Zhu et al. | L‐Arg‐rich amphiphilic dendritic peptide as a versatile NO donor for NO/photodynamic synergistic treatment of bacterial infections and promoting wound healing | |
| Pierce et al. | Evidence for direct inhibition of dentinoclasts by a corticosteroid/antibiotic endodontic paste | |
| GEP20022804B (en) | Erythropoietin Derivatives | |
| ES2136673T3 (es) | Utilizacion del factor de crecimiento de los queratinocitos para la obtencion de medicamentos. | |
| DE69731083T2 (de) | Verfahren zur behandlung von viralen infektionen | |
| EP1342476A3 (de) | FGFR3 als Marker für mesenchymale skeletale Vorläuferzellen und Verwendung von cytoxischen Konjugaten enthaltend eine FGFR3 bindende Gruppe für die Behandlung von Tumoren des Knorpels oder des Knochens | |
| RU94046426A (ru) | Фармацевтические композиции, способы лечения лейкоза, способ повышения уровней стволовых клеток, антагонист с - kit - лиганда, антисмысловая нуклеиновая кислота, способ лечения меланомы, способ усиления трансфекции, способ переноса гена, способ увеличения уровней периферической крови, способ повышения уровней тромбоцитов, способы модификации биологической функции, способ лечения анемии, способ улучшения приживления костного мозга, способ ускорения восстановления костного мозга, способ лечения лейкопении | |
| WO2001038303A3 (fr) | Analogues de la vitamine d | |
| RU95110937A (ru) | Хинолоновые и акридиноновые соединения, способ их получения, фармацевтическая композиция и промежуточные соединения | |
| US20250281676A1 (en) | Delivery of cells and tissues with self-assembling peptide hydrogel materials | |
| AU6721998A (en) | Therapeutic use of the smr1 protein and active derivatives thereof | |
| CA2169173A1 (en) | Methods for stimulating erythropoiesis using thrombopoietin | |
| CA2449856A1 (en) | Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells | |
| CA3188240A1 (en) | Antimicrobial matrix formed from peptide hydrogels | |
| JPH10502371A (ja) | リンホトキシンを用いる癌処置法 | |
| WO1996015758A3 (en) | Methods for stimulating erythropoiesis using thrombopoietin | |
| AU5643299A (en) | Humic acid and its use in the treatment of various conditions | |
| PT941110E (pt) | Utilizacao do factor 2 de crescimento dos ceratinocitos | |
| ATE151288T1 (de) | N-acetyl-cysteine derivate enthaltende pharmazeutische zusammensetzung zur behandlung von katarakt | |
| DK1165102T3 (da) | Matrixproteinpræparater til podning i ikke-mineraliseret væv | |
| CN1163218C (zh) | 新型护肤化妆品 | |
| DK0588477T3 (da) | Medicinsk præparat omfatende TCF-11 | |
| AU2018363797A1 (en) | Composition for the treatment of intracellular bacterial infection | |
| RU95105249A (ru) | Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения |